The trajectory of medical cannabis sales in Arkansas continues to set new records, with transactions in the state soaring to $23.2 million in July. This robust performance propels the total sales of medical marijuana in Arkansas for the initial seven months of 2023 to an impressive $164.6 million. Remarkably, this figure surpasses the corresponding period’s sales from the previous year by a substantial margin of $7.3 million, as reported by Fayetteville TV station KNWA.

One notable factor contributing to this surge in sales is the marked increase in the number of medical marijuana cardholders within the state. Since the advent of August 2022, the count of patients has surged from 88,893 to 94,059, in accordance with data provided by the Arkansas health department. This expanding patient base is undoubtedly bolstering the state’s medical cannabis market.

Scott Hardin, the official spokesperson for Arkansas’ Department of Finance and Administration, has expressed optimism regarding the foreseeable sales trajectory. He stated that if the current sales patterns persist over the coming months, the total sales for the entirety of 2023 could potentially exceed an impressive $280 million.

In the realm of specific sales figures, medical marijuana dispensaries in Arkansas have effectively marketed and distributed 29,057 pounds of medical cannabis during the initial six months of 2023. This noteworthy achievement reflects a remarkable 23% increase when juxtaposed with the analogous period in the previous year.

The state’s proactive approach to medical cannabis regulation and the growing acceptance of its therapeutic benefits are likely contributors to the surging sales figures. With an expanding patient base and a positive trajectory in sales, Arkansas is solidifying its position as a significant player in the medical cannabis industry.

Arkansas’ medical cannabis market continues to make substantial strides, as evidenced by the record-breaking sales figures in July and the overall upward trend in transactions throughout 2023. The expanding number of medical marijuana cardholders and the persistent efforts of dispensaries are collectively driving this exceptional performance. The state’s potential to achieve sales exceeding $280 million for the year underscores the robust growth of the medical cannabis sector in Arkansas.

 

Source: Mjbizdaily

EXPLORE MORE NEWS

Major Corporations Investing in Cannabis

As cannabis legalization continues to spread across the country, major corporations are increasingly taking notice and investing in the industry. In April of 2023, a major beverage company announced a $100 million investment in a cannabis-infused drink startup, signaling the growing trend of large corporations entering the cannabis space.

Ohio Joins Ranks of Legal Cannabis States as Issue 2 Passes with 57% Voter Approval

In a groundbreaking decision, Ohio has officially become the 24th state to legalize adult-use cannabis. With a resounding 57% of voters supporting the ballot proposal known as Issue 2, this victory marks a significant shift in the landscape of U.S. states where recreational marijuana is legal. This landmark decision paves the way for individuals aged 21 and older to purchase and possess up to 2.5 ounces of cannabis while also permitting home cultivation of up to six plants per person and 12 plants per residence if at least two adults reside there. Furthermore, a 10% tax will be levied on cannabis purchases, with the revenue allocated to cover administrative costs, addiction treatment programs, municipalities with dispensaries, and social equity initiatives and job programs.

Georgia Approves Independent Pharmacies to Sell Cannabis Oil, Expanding Access to Medical Treatment

Georgia’s regulatory authorities have taken a significant step towards improving access to medical cannabis treatment for patients in the state. The state Board of Pharmacy has recently introduced a set of regulations that will allow independent pharmacies in Georgia to dispense cannabis oil to eligible patients enrolled in the state Department of Public Health’s registry, as reported by Northwest Georgia News.

Blue Dream’s Two Decades of Influence: Unraveling the Origins and Impact

From Haze to Skunk, OG to Cookies, the cannabis market has been shaped by remarkable strains that encapsulate their respective eras. Among them, Blue Dream emerged as a defining cultivar around 2003, reigning until approximately 2011 when shifting market preferences opened the door for a new strain to take the spotlight. As we commemorate two decades of Blue Dream’s legacy, it’s intriguing to note that despite its celebrated status as the “most popular strain on the planet” at one point, there remains a surprising shroud of uncertainty surrounding its true origins and characteristics.

Newsletter